Incyte Corporation (INCY)
$112.79+0.04%Close
SELLBEAR · day 8
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $22.9B
- Beta
- 0.74
- P/E (TTM)
- 13.87
- Short % float
- 4.97%
- Days to cover
- 6.1
- SI change
- +0.1%
- 1W
- -2.18%
- 1M
- -8.51%
- vs SPY 1W
- -3.34%
- vs SPY 1M
- -11.50%
Industry peers
FMP comparable companies · ranked by market cap
- REGNSELLRegeneron Pharmaceuticals, Inc.$76.1BBEARQ 24$738.72+0.94%
- GMABBUYGenmab A/S$23.2BBULLQ 21$37.80+2.83%
- EXELBUYExelixis, Inc.$14.7BBULLQ 10$58.33+1.42%
- LGNDBUYLigand Pharmaceuticals Incorporated$6.0BRECOVERYQ 15$296.94+2.31%
- LEGNSELLLegend Biotech Corporation$3.5BRECOVERYQ 2$18.72-0.48%
- NRIXSELLNurix Therapeutics, Inc.$2.3BBEARQ 11$22.60+0.63%
- SLSSELLSELLAS Life Sciences Group, Inc.$2.1BBEARQ -9$11.34+3.46%
- CGEMSELLCullinan Therapeutics, Inc.$999MCRISISQ 2$16.25+0.45%
- AVBPSELLArriVent BioPharma, Inc.$703MCRISISQ -5$15.09+0.12%
- VSTMBUYVerastem, Inc.$681MRECOVERYQ 4$7.75+3.33%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
